US6951271005
US6951271005
Pacira BioSciences, Inc.
Loading chart...
Financials
Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
| Breakdown | 2025 | 2024 | Change % |
|---|---|---|---|
| Total Revenue | 726.411.000 | 700.966.000 | 3.6% |
| Cost of Revenue | 149.749.000 | 170.428.000 | 12.1% |
| Gross Profit | 576.662.000 | 530.538.000 | 8.7% |
| 557.471.000 | 440.666.000 | 26.5% | |
| Operating Income | 19.191.000 | 89.872.000 | 78.6% |
| Pretax Income | 16.874.000 | -63.106.000 | 126.7% |
| Net Income Common Stockholders | 7.034.000 | -99.560.000 | 107.1% |
| -- | -- | -- | |
| -- | -- | -- |